AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway.

MLA

Zhu, Guoqing, et al. “AURKB Targets DHX9 to Promote Hepatocellular Carcinoma Progression via PI3K/AKT/MTOR Pathway.” Molecular Carcinogenesis, vol. 63, no. 9, Sept. 2024, pp. 1814–26. EBSCOhost, https://doi.org/10.1002/mc.23775.

APA

Zhu, G., Luo, L., He, Y., Xiao, Y., Cai, Z., Tong, W., Deng, W., Xie, J., Zhong, Y., Hu, Z., & Shan, R. (2024). AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway. Molecular Carcinogenesis, 63(9), 1814–1826. https://doi.org/10.1002/mc.23775

Chicago

Zhu, Guoqing, Laihui Luo, Yongzhu He, Yongqiang Xiao, Ziwei Cai, Weilai Tong, Wei Deng, et al. 2024. “AURKB Targets DHX9 to Promote Hepatocellular Carcinoma Progression via PI3K/AKT/MTOR Pathway.” Molecular Carcinogenesis 63 (9): 1814–26. doi:10.1002/mc.23775.